Michelle Frascella

550 total citations
10 papers, 365 citations indexed

About

Michelle Frascella is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, Michelle Frascella has authored 10 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 4 papers in Epidemiology and 3 papers in Rheumatology. Recurrent topics in Michelle Frascella's work include Lysosomal Storage Disorders Research (8 papers), Trypanosoma species research and implications (4 papers) and Glycogen Storage Diseases and Myoclonus (3 papers). Michelle Frascella is often cited by papers focused on Lysosomal Storage Disorders Research (8 papers), Trypanosoma species research and implications (4 papers) and Glycogen Storage Diseases and Myoclonus (3 papers). Michelle Frascella collaborates with scholars based in United States and South Africa. Michelle Frascella's co-authors include Richie Khanna, Kenneth J. Valenzano, Jessie Feng, Yi Lun, Rebecca Soska, David J. Lockhart, Lee Pellegrino, Nastry Brignol, Elfrida R. Benjamin and Brandy Young and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Michelle Frascella

9 papers receiving 348 citations

Peers

Countries citing papers authored by Michelle Frascella

Since Specialization

Citations

This map shows the geographic impact of Michelle Frascella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Frascella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Frascella more than expected).

Fields of papers citing papers by Michelle Frascella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Frascella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Frascella. The network helps show where Michelle Frascella may publish in the future.

Co-authorship network of co-authors of Michelle Frascella

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Frascella. A scholar is included among the top collaborators of Michelle Frascella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Frascella. Michelle Frascella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Discovery of Fluoroalkenes as Dual Inhibitors of Diacylglycerol Kinases Alpha and Zeta (DGKα/ζ) 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Shiquan Qian, Cheng‐Tsung Lai, Kelly Federowicz, Guofeng Zhang, Melissa Chan, David Rodrigues, (unknown), (unknown), Gengjie Yang, Maryanne Covington, Lisa Truong, Michelle Frascella, (unknown), Patrick A. Mayes, (unknown), (unknown), Joshua R. Hummel, Xiaozhao Wang	0
2	Improved efficacy of a next-generation ERT in murine Pompe disease 2019 ·JCI Insight ·Su Xu, Yi Lun, Michelle Frascella, (unknown), Rebecca Soska, Anju Nair, A. S. Ponery, Adriane Schilling, Jessie Feng, Steven Tuske, Maria Cecilia Della Valle, José A. Martina, Evelyn Ralston, Russell Gotschall, Kenneth J. Valenzano, Rosa Puertollano, (unknown), Nina Raben, Richie Khanna	59
3	Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease 2017 ·Analytical Chemistry ·Rick Hamler, Nastry Brignol, Sean W. Clark, Sean J. Morrison, (unknown), Hui Hua Chang, Richie Khanna, Michelle Frascella, Kenneth J. Valenzano, Elfrida R. Benjamin, Robert E. Boyd	22
4	Novel recombinant human acid α-glucosidase with optimal glycosylation is significantly better than standard of care enzyme replacement for glycogen clearance in skeletal muscles of GAA knock-out mice 2015 ·Molecular Genetics and Metabolism ·Russell Gotschall, Su Xu, Yi Lun, Adriane Schilling, Rebecca Soska, Michelle Frascella, (unknown), Jessie Feng, (unknown), Nastry Brignol, Richie Khanna, Kenneth J. Valenzano, Hung Do	5
5	The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease 2014 ·PLoS ONE ·Richie Khanna, Allan Powe, Yi Lun, Rebecca Soska, Jessie Feng, (unknown), Michelle Frascella, (unknown), Lee Pellegrino, Su Xu, Nastry Brignol, Matthew J. Toth, (unknown), David J. Lockhart, Brandon A. Wustman, Kenneth J. Valenzano	31
6	Exploring the use of a co-formulated pharmacological chaperone AT2220 with recombinant human acid alpha-glucosidase for Pompe disease 2013 ·Molecular Genetics and Metabolism ·Richie Khanna, Su Xu, Yi Lun, Rebecca Soska, Jessie Feng, Michelle Frascella, (unknown), John J. Flanagan, David J. Lockhart, Kenneth J. Valenzano	1
7	The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease 2012 ·PLoS ONE ·Richie Khanna, John J. Flanagan, Jessie Feng, Rebecca Soska, Michelle Frascella, Lee Pellegrino, Yi Lun, (unknown), David J. Lockhart, Kenneth J. Valenzano	66
8	Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice 2012 ·Molecular Therapy ·Elfrida R. Benjamin, Richie Khanna, Adriane Schilling, John J. Flanagan, Lee Pellegrino, Nastry Brignol, Yi Lun, (unknown), (unknown), Michelle Frascella, Rebecca Soska, Jessie Feng, (unknown), Brandy Young, David J. Lockhart, Kenneth J. Valenzano	71
9	Exploring the Use of Pharmacological Chaperone AT3375 Alone and in Combination with Recombinant human ß-Glucosidase for Gaucher Disease 2012 ·Molecular Genetics and Metabolism ·Richie Khanna, Lee Pellegrino, Rebecca Soska, Yi Lun, Jessie Feng, Michelle Frascella, (unknown), (unknown), (unknown), John J. Flanagan, David J. Lockhart, Sean W. Clark, Kenneth J. Valenzano	3
10	The Pharmacological Chaperone 1-Deoxygalactonojirimycin Reduces Tissue Globotriaosylceramide Levels in a Mouse Model of Fabry Disease 2009 ·Molecular Therapy ·Richie Khanna, Rebecca Soska, Yi Lun, Jessie Feng, Michelle Frascella, Brandy Young, Nastry Brignol, Lee Pellegrino, Sheela Sitaraman, Robert J. Desnick, Elfrida R. Benjamin, David J. Lockhart, Kenneth J. Valenzano	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact